Literature DB >> 2274742

Gastroduodenal lesions induced by naproxen. An endoscopic evaluation of regional differences and natural course.

L Aabakken1, M Osnes.   

Abstract

Gastroduodenal endoscopic findings were studied in 65 healthy volunteers receiving 750 mg or 1000 mg naproxen for 1 or 2 weeks. Separate registration of the mid- and distal duodenum showed that mucosal toxicity can be demonstrated even distally to the duodenal bulb. The lesions were closely correlated to the findings in the stomach and duodenal bulb, though generally somewhat less extensive. Whereas a difference between 750 mg and 1000 mg naproxen was demonstrated in an intraindividual comparison (n = 26; median sum of visual analogue scale score in the stomach/duodenal bulb, 129 mm and 183 mm, respectively; p less than 0.05), no difference was seen in two parallel groups (n = 32 and 33). In the stomach and duodenal bulb, a significant aggravation of mucosal lesions was seen from 1 to 2 weeks in 16 subjects. Healing was complete in 10/12 subjects after 3 weeks, independent of the extent of the initial damage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2274742     DOI: 10.3109/00365529008998556

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  2 in total

Review 1.  Are perioperative nonsteroidal anti-inflammatory drugs ulcerogenic in the short term?

Authors:  H Kehlet; J B Dahl
Journal:  Drugs       Date:  1992       Impact factor: 9.546

2.  Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial.

Authors:  Thiago Gagliano-Jucá; Ronilson A Moreno; Tiago Zaminelli; Mauro Napolitano; Antônio Frederico N Magalhães; Aloísio Carvalhaes; Miriam S Trevisan; John L Wallace; Gilberto De Nucci
Journal:  BMC Gastroenterol       Date:  2016-06-04       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.